24 results on '"Christiaans, I."'
Search Results
2. Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance
3. Recurrent variant of unknown significance in KCNH2 classified through functional characterisation
4. Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands*
5. Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6*
6. Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
7. BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
8. Altered auto-phosphorylation of novel TNNI3K variants associated with AV-nodal re-entry tachycardia and conduction disease
9. How to inform relatives at risk of hereditary diseases? A mixed‐methods systematic review on patient attitudes
10. Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice
11. Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
12. P333HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy
13. Characterisation of familial idiopathic ventricular fibrillation linked to DPP6
14. Novel HCN4 mutations in families with bradycardia and hypertrabeculation of the myocardium
15. Mortality and risk factors for malignant ventricular arrhythmias in carriers of the phospholamban R14del mutation
16. Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers
17. Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6
18. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy
19. The patient with hypertrophic cardiomyopathy has a family
20. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas
21. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers
22. Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands
23. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers
24. ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.